XML 76 R64.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Subsequent Events (Details Narrative) (10-K) - USD ($) |  | 1 Months Ended | 6 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | ---
Oct. 04, 2017 | Mar. 31, 2018 | Jan. 31, 2018 | Jun. 30, 2018 | Jun. 30, 2017 | Mar. 19, 2018 | Dec. 31, 2017 | Dec. 31, 2016
Number of common stock shares outstanding |  |  |  | 38,674,265 |  |  | 35,272,626 | 31,745,242
Gross proceeds from equity or other financing |  |  |  | $ 117,339 |  |  |  |
Loss on cyber security fraud |  |  |  | $ 144,200 |  |  |  |
Parent Company [Member] |  |  |  |  |  |  |  |
Number of common stock shares outstanding |  |  |  |  |  |  | 246,907,902 |
CoNCERT Pharmaceuticals, Inc [Member] |  |  |  |  |  |  |  |
Number of common stock shares outstanding |  |  |  |  |  | 35,272,626 |  |
Gross proceeds from equity or other financing | $ 8,000,000 |  |  |  |  |  |  |
Subsequent Event [Member] |  |  |  |  |  |  |  |
Percentage of sublicense revenue earned |  | 15.00% |  |  |  |  |  |
Loss on cyber security fraud |  |  | $ 144,200 |  |  |  |  |
Subsequent Event [Member] | Parent Company [Member] |  |  |  |  |  |  |  |
Percentage of sublicense revenue earned |  | 0.00% |  |  |  |  |  |
Gross proceeds from equity or other financing |  | $ 8,000,000 |  |  |  |  |  |
Sublicense revenue |  | 8,000,000 |  |  |  |  |  |
Subsequent Event [Member] | CoNCERT Pharmaceuticals, Inc [Member] |  |  |  |  |  |  |  |
Amount of common stock owned |  | $ 8,000,000 |  |  |  |  |  |
Number of common stock shares outstanding |  | 2,090,300 |  |  |  |  |  |
Subsequent Event [Member] | Promet Therapeutics, LLC [Member] |  |  |  |  |  |  |  |
Common stock percentage |  | 6.58% |  |  |  |  |  |
Common stock issued and outstanding percentage |  | 5.93% |  |  |  |  |  |

X
- Definition Common stock issued and outstanding percentage. + References No definition available. + Details
Name: | PCSA_CommonStockIssuedAndOutstandingPercentage
Namespace Prefix: | PCSA_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common stock percentage. + References No definition available. + Details
Name: | PCSA_CommonStockPercentage
Namespace Prefix: | PCSA_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss on Cybersecurity Fraud. + References No definition available. + Details
Name: | PCSA_LossOnCybersecurityFraud
Namespace Prefix: | PCSA_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of sublicense revenue earned. + References No definition available. + Details
Name: | PCSA_PercentageOfSublicenseRevenueEarned
Namespace Prefix: | PCSA_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sublicense revenue. + References No definition available. + Details
Name: | PCSA_SublicenseRevenue
Namespace Prefix: | PCSA_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValueOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of cash inflow (outflow) from financing activities classified as other. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585 + Details
Name: | us-gaap_ProceedsFromPaymentsForOtherFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_CoNCERTPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=PCSA_PrometTherapeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |